Morse Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,885
Closed -$948K 143
2022
Q2
$948K Sell
11,885
-1,115
-9% -$88.9K 0.3% 83
2022
Q1
$1.37M Sell
13,000
-19,370
-60% -$2.04M 0.34% 78
2021
Q4
$3.49M Sell
32,370
-6,680
-17% -$720K 0.78% 37
2021
Q3
$4.28M Buy
39,050
+6,750
+21% +$739K 1.02% 26
2021
Q2
$3.03M Buy
32,300
+14,900
+86% +$1.4M 0.73% 36
2021
Q1
$1.6M Buy
17,400
+11,435
+192% +$1.05M 0.41% 62
2020
Q4
$436K Buy
5,965
+2,865
+92% +$209K 0.12% 110
2020
Q3
$241K Buy
+3,100
New +$241K 0.08% 120